Literature DB >> 9150366

A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors.

L M Kalikin1, T S Frank, S M Svoboda-Newman, J C Wetzel, K A Cooney, E M Petty.   

Abstract

Chromosomal regions of allelic imbalance in tumors are predicted to define the general location of tumor suppressor genes. We previously localized a putative breast tumor suppressor gene to a 3 cM region on 17q25 by deletion mapping of microsatellite markers in breast tumors. To determine if the same 17q25 region of loss is important in the genesis of other tumor types, 32 ovarian tumors and 24 prostate tumors, as well as 33 additional breast tumors, were analysed with 17q25 polymorphic microsatellite markers. While no significant loss was observed in prostate tumors, greater than half of ovarian tumors exhibited loss coincident with the candidate region previously defined in breast tumors. These results suggest that one or more novel tumor suppressor genes exist on 17q25 within a concordant region of interstitial loss defined in both breast and ovarian neoplasms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150366     DOI: 10.1038/sj.onc.1201013

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  Conquering the complex world of human septins: implications for health and disease.

Authors:  E A Peterson; E M Petty
Journal:  Clin Genet       Date:  2010-02-11       Impact factor: 4.438

2.  Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity.

Authors:  S Maudsley; A M Zamah; N Rahman; J T Blitzer; L M Luttrell; R J Lefkowitz; R A Hall
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 3.  Applying circulating tumor DNA methylation in the diagnosis of lung cancer.

Authors:  Lei Li; Kai Fu; Wenyu Zhou; Michael Snyder
Journal:  Precis Clin Med       Date:  2019-03-15

4.  Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.

Authors:  Esther A Peterson; Linda M Kalikin; Jonathan D Steels; Mathew P Estey; William S Trimble; Elizabeth M Petty
Journal:  Mamm Genome       Date:  2007-10-06       Impact factor: 2.957

5.  Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.

Authors:  K Dolan; J Garde; J Gosney; M Sissons; T Wright; A N Kingsnorth; S J Walker; R Sutton; S J Meltzer; J K Field
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

6.  Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.

Authors:  J Edwards; P Duncan; J J Going; K M Grigor; A D Watters; J M Bartlett
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

7.  Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.

Authors:  Yong Pan; Edward J Weinman; Jia Le Dai
Journal:  Breast Cancer Res       Date:  2008-01-11       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.